Clearmind Medicine Inc. is a clinical-stage pharmaceutical company focused on developing 5-methoxy-2-aminoindane (MEAI), a psychedelic-derived compound, for the treatment of alcohol use disorder (AUD) and obesity and metabolic disorder. Incorporated in British Columbia, Canada, with operations partly in Israel, the company has not commercialized any products, has incurred losses since inception totaling an accumulated deficit of $27,879,724 as of October 31, 2025, and relies on preclinical and clinical development activities.
167 total filings indexed. 167 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001892500 |
| Ticker | CMND |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | Z4 |
| Headquarters | British Columbia, Canada |
| Website | https://www.clearmindmedicine.com |
| Listed | 2021-08-10 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CMND (~200 tokens, structured JSON with cryptographic provenance)